NO306511B1 -
Recombinant vector that selectively hybridizes to the genome of hepatitis C virus (HCV), a host cell transformed with the vector, and a method for producing a therapeutically active polypeptide
- Google Patents
Recombinant vector that selectively hybridizes to the genome of hepatitis C virus (HCV), a host cell transformed with the vector, and a method for producing a therapeutically active polypeptide
Info
Publication number
NO306511B1
NO306511B1NO955101ANO955101ANO306511B1NO 306511 B1NO306511 B1NO 306511B1NO 955101 ANO955101 ANO 955101ANO 955101 ANO955101 ANO 955101ANO 306511 B1NO306511 B1NO 306511B1
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from NO892931Aexternal-prioritypatent/NO304990B1/en
Application filed by Chiron CorpfiledCriticalChiron Corp
Publication of NO955101LpublicationCriticalpatent/NO955101L/en
Publication of NO955101D0publicationCriticalpatent/NO955101D0/en
Publication of NO306511B1publicationCriticalpatent/NO306511B1/en
NO955101A1987-11-181995-12-15
Recombinant vector that selectively hybridizes to the genome of hepatitis C virus (HCV), a host cell transformed with the vector, and a method for producing a therapeutically active polypeptide
NO306511B1
(en)
Recombinant vector that selectively hybridizes to the genome of hepatitis C virus (HCV), a host cell transformed with the vector, and a method for producing a therapeutically active polypeptide
Recombinant plasmid inserted with hepatitis b virus gene,yeast transformed with said recombinant plasmid and production of hepatitis b virus surface antigen
DERIVATIVES OF HUMANT INTERFERON-GAMMA POLYPEPTIDE, RECOMBINANT PLASMIDE USED IN PREPARING THEREOF, PROCEDURES FOR PRODUCING THEREOF AND MICROORGANISM CONTAINING RECOMBINANT PLASMID
Novel physiologically active polypeptide, recombinant plasmid, recombinant microbial cells, medicinal composition, and process for recovering purified polypeptide
Recombinant vector that selectively hybridizes to the genome of hepatitis C virus (HCV), a host cell transformed with the vector, and a method for producing a therapeutically active polypeptide
POLYPEPTIDE WITH CYSTATIN C ACTIVITY, DNA SEQUENCE FOR EXPRESSION OF 3-DES-OH CYSTATIN C OR A MODIFICATION THEREOF, PROCEDURES FOR THE PREPARATION OF 3-DES-HYDROXY-CYSTATINE MELDOMMANE MADRIDME OR MADIFICANE MADRIDME USE OF 3-DES-OH CYSTATIN C OR ITS MODIFICATION FOR THE PREPARATION OF A THERAPEUTIC PREPARATION